158 related articles for article (PubMed ID: 2751268)
41. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
[TBL] [Abstract][Full Text] [Related]
42. Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
Thiele J; Zankovich R; Steinberg T; Fischer R; Diehl V
Hematol Oncol; 1989; 7(5):327-43. PubMed ID: 2767619
[TBL] [Abstract][Full Text] [Related]
43. Idiopathic myelofibrosis: a retrospective study of 103 patients.
Anger B; Seidler R; Haug U; Popp C; Heimpel H
Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
Buesche G; Georgii A; Kreipe HH
Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
[TBL] [Abstract][Full Text] [Related]
45. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow features of diagnostic impact in erythrocytosis.
Thiele J; Kvasnicka HM; Diehl V
Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
[TBL] [Abstract][Full Text] [Related]
47. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
[TBL] [Abstract][Full Text] [Related]
48. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients.
Ozen S; Ferhanoğlu B; Senocak M; Tüzüner N
Leuk Res; 1997 Feb; 21(2):125-31. PubMed ID: 9112429
[TBL] [Abstract][Full Text] [Related]
49. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
[TBL] [Abstract][Full Text] [Related]
50. Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia.
Buesche G; Georgii A; Duensing A; Schmeil A; Schlue J; Kreipe HH
Hum Pathol; 2003 Apr; 34(4):391-401. PubMed ID: 12733122
[TBL] [Abstract][Full Text] [Related]
51. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
[TBL] [Abstract][Full Text] [Related]
52. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
[TBL] [Abstract][Full Text] [Related]
53. European consensus on grading bone marrow fibrosis and assessment of cellularity.
Thiele J; Kvasnicka HM; Facchetti F; Franco V; van der Walt J; Orazi A
Haematologica; 2005 Aug; 90(8):1128-32. PubMed ID: 16079113
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
55. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years].
Yamagishi M; Yamamoto T; Ohmori M
Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165
[TBL] [Abstract][Full Text] [Related]
56. Osteomyelosclerosis. A histopathological study of osteomedullary lesions on 32 cases.
Leibovici M
Morphol Embryol (Bucur); 1975; 21(1):35-41. PubMed ID: 127935
[TBL] [Abstract][Full Text] [Related]
57. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
Sem Hop; 1979 Oct 18-25; 55(35-36):1623-8. PubMed ID: 231834
[TBL] [Abstract][Full Text] [Related]
58. Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature.
Yablonski-Peretz T; Sulkes A; Polliack A; Weshler Z; Okon E; Catane R
Med Pediatr Oncol; 1985; 13(2):92-6. PubMed ID: 3982370
[TBL] [Abstract][Full Text] [Related]
59. Myelofibrosis--pathophysiology and treatment.
Cole DR; Pung J; Pung F; Cole DF
Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):68-70. PubMed ID: 370037
[TBL] [Abstract][Full Text] [Related]
60. Idiopathic myelofibrosis (agnogenic myeloid metaplasia) in a marmoset (Callithrix jacchus): hematologic and histopathologic changes.
Khan KN; Logan AC; Blomquist EM
Vet Pathol; 1997 Jul; 34(4):341-5. PubMed ID: 9240843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
